DIANTHUS THERAPEUTICS
Dianthus Therapeutics is a biotech company operating in stealth mode. It was founded in 2019 and is based in Waltham, Massachusetts.
DIANTHUS THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.dianthustx.com
Total Employee:
11+
Status:
Active
Contact:
781-795-4723
Total Funding:
121.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag Nginx Sitelinks Search Box Organization Schema
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Investors List
Avidity Partners
Avidity Partners investment in Series A - Dianthus Therapeutics
Tellus BioVentures
Tellus BioVentures investment in Series A - Dianthus Therapeutics
Fairmount Funds Management
Fairmount Funds Management investment in Series A - Dianthus Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series A - Dianthus Therapeutics
Wedbush Securities
Wedbush Securities investment in Series A - Dianthus Therapeutics
5AM Ventures
5AM Ventures investment in Series A - Dianthus Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series A - Dianthus Therapeutics
Official Site Inspections
http://www.dianthustx.com Semrush global rank: 5.7 M Semrush visits lastest month: 1.47 K
- Host name: 24.20.185.35.bc.googleusercontent.com
- IP address: 35.185.20.24
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Dianthus Therapeutics"
Careers - Dianthus Therapeutics
Jul 21, 2023 The official recruiters at Dianthus only use email addresses with the domain “@dianthustx.com”. All other domains, even if they closely resemble @dianthustx.com, are not …See details»
Dianthus Therapeutics, Inc. (DNTH) - Yahoo Finance
See the company profile for Dianthus Therapeutics, Inc. (DNTH) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Dianthus Therapeutics, Inc. | LinkedIn
Dianthus Therapeutics, Inc. | 5,525 followers on LinkedIn. Unlocking the full potential of complement therapeutics through the power of selectivity. | Dianthus Therapeutics is a clinical …See details»
Dianthus Therapeutics - Crunchbase Company Profile …
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach. DNTH103 is a …See details»
Dianthus Therapeutics OpCo, Inc. - Drug pipelines, Patents
Www.dianthustx.com. Startups | Public Company | Subsidiary Company | 2019 | Massachusetts, United States | 10-50 | NASDAQ: DNTH | www.dianthustx.com. Last update 01 Nov 2024. …See details»
Dianthus Therapeutics Company Profile | Management and
[email protected]: Dianthus Therapeutics Top Competitors. Company Employees Revenue Top technologies; Creative BioLabs. 36: $4.3 M: MedAbome. 16: $3.7 M: Bayhill Therapeutics. …See details»
Dianthus - Bain Capital Life Sciences
Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. …See details»
Dianthus Therapeutics - Overview, News & Similar companies
Dianthus Therapeutics contact info: Phone number: (929) 999-4055 Website: www.dianthustx.com What does Dianthus Therapeutics do? Dianthus Therapeutics is a clinical …See details»
Dianthus Therapeutics - PitchBook
Dianthus Therapeutics General Information Description. Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency …See details»
May 3, 2022 4:00 AM EDT - investor.dianthustx.com
To learn more, please visit www.dianthustx.com . Media Contact Amanda Sellers, Verge Scientific Communications [email protected]. Link annotation. Link annotation. Title: …See details»
Dianthus Therapeutics to Participate in Three Healthcare Investor ...
Sep 4, 2024 To learn more, please visit www.dianthustx.com and follow us on LinkedIn. Contact Jennifer Davis Ruff Dianthus Therapeutics [email protected]. Dianthus Therapeutics. …See details»
Magenta Therapeutics Announces Completion of Merger with …
Sep 11, 2023 The combined company will operate as “Dianthus Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “DNTH” effective Tuesday, September …See details»
Org Chart Dianthus Therapeutics - The Official Board
For each of our 1,259,204 listed executives, discover their exact roles and their biographies.See details»
Dianthus Therapeutics - Work in biotech
Dianthus Therapeutics is developing novel Complement therapeutics to improve the quality of life of patients with autoimmune diseases. The Complement system is part of the innate immune …See details»
SEC Filing - Dianthus Therapeutics
EXPLANATORY NOTE . This Amendment No. 1 to Form S-1 (this “Amendment”) amends the registration statement of Dianthus Therapeutics, Inc. on Form S-3, originally filed with the U.S. …See details»
Dianthus Therapeutics, Inc. Staff Directory & Email Format
Explore Dianthus Therapeutics, Inc. staff directory for direct access to contact details on 43 employees including email format, email address and phone numbers.See details»
Approach and Pipeline - Dianthus Therapeutics
Jul 21, 2023 An Internet Protocol (IP) address is a set of numbers that is automatically assigned to your computer whenever you log on to your internet service provider or through your …See details»
DNTH-103 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 To learn more, please visit www.dianthustx.com and follow us on LinkedIn. ... CEO, Hesperos, Inc. Hesperos, Inc. Hesperos is a global contract research organization …See details»
Anne McGeorge - Board Member - Dianthus Therapeutics
Nov 8, 2024 Anne McGeorge has almost 40 years of experience providing strategic guidance and operational oversight to health care organizations. Ms. McGeorge is a director at The …See details»